Free Trial

Dyadic International (DYAI) Competitors

Dyadic International logo
$1.10 -0.02 (-1.79%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.08 -0.02 (-1.82%)
As of 07/25/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DYAI vs. HURA, BHST, ACTU, CTNM, ANIX, CTOR, ATOS, SAVA, CRBP, and HLVX

Should you be buying Dyadic International stock or one of its competitors? The main competitors of Dyadic International include TuHURA Biosciences (HURA), BioHarvest Sciences (BHST), Actuate Therapeutics (ACTU), Contineum Therapeutics (CTNM), ANIXA BIOSCIENCES (ANIX), Citius Oncology (CTOR), Atossa Genetics (ATOS), Cassava Sciences (SAVA), Corbus Pharmaceuticals (CRBP), and HilleVax (HLVX). These companies are all part of the "pharmaceutical products" industry.

Dyadic International vs. Its Competitors

TuHURA Biosciences (NASDAQ:HURA) and Dyadic International (NASDAQ:DYAI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

0.6% of TuHURA Biosciences shares are owned by institutional investors. Comparatively, 28.0% of Dyadic International shares are owned by institutional investors. 0.2% of TuHURA Biosciences shares are owned by insiders. Comparatively, 29.5% of Dyadic International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

TuHURA Biosciences currently has a consensus target price of $12.67, suggesting a potential upside of 344.44%. Dyadic International has a consensus target price of $6.00, suggesting a potential upside of 445.45%. Given Dyadic International's higher possible upside, analysts clearly believe Dyadic International is more favorable than TuHURA Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TuHURA Biosciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40
Dyadic International
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

TuHURA Biosciences has a net margin of 0.00% compared to Dyadic International's net margin of -163.94%. TuHURA Biosciences' return on equity of 291.69% beat Dyadic International's return on equity.

Company Net Margins Return on Equity Return on Assets
TuHURA BiosciencesN/A 291.69% 122.09%
Dyadic International -163.94%-233.69%-59.37%

Dyadic International has higher revenue and earnings than TuHURA Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TuHURA BiosciencesN/AN/A-$21.68MN/AN/A
Dyadic International$3.49M9.48-$5.81M-$0.20-5.50

In the previous week, TuHURA Biosciences had 4 more articles in the media than Dyadic International. MarketBeat recorded 5 mentions for TuHURA Biosciences and 1 mentions for Dyadic International. Dyadic International's average media sentiment score of 1.89 beat TuHURA Biosciences' score of 0.68 indicating that Dyadic International is being referred to more favorably in the news media.

Company Overall Sentiment
TuHURA Biosciences Positive
Dyadic International Very Positive

TuHURA Biosciences has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500. Comparatively, Dyadic International has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.

Summary

TuHURA Biosciences and Dyadic International tied by winning 7 of the 14 factors compared between the two stocks.

Get Dyadic International News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DYAI vs. The Competition

MetricDyadic InternationalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$33.70M$3.07B$5.70B$9.50B
Dividend YieldN/A2.37%4.69%4.01%
P/E Ratio-5.5021.1828.1020.06
Price / Sales9.48283.55428.7189.10
Price / CashN/A42.7636.2258.56
Price / Book13.758.378.665.87
Net Income-$5.81M-$55.19M$3.25B$258.55M
7 Day Performance12.96%5.88%4.22%3.73%
1 Month Performance10.55%17.33%10.51%11.75%
1 Year Performance-29.03%4.42%34.40%18.02%

Dyadic International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DYAI
Dyadic International
3.2916 of 5 stars
$1.10
-1.8%
$6.00
+445.5%
-22.0%$33.70M$3.49M-5.507Positive News
Gap Down
HURA
TuHURA Biosciences
1.7792 of 5 stars
$2.55
-2.7%
$12.67
+396.7%
N/A$114.44MN/A0.00N/A
BHST
BioHarvest Sciences
N/A$6.84
-1.2%
$13.67
+99.8%
N/A$113.66M$25.19M-13.68N/ANews Coverage
ACTU
Actuate Therapeutics
2.3747 of 5 stars
$5.66
-1.7%
$20.50
+262.2%
N/A$113.01MN/A0.0010News Coverage
CTNM
Contineum Therapeutics
3.3652 of 5 stars
$5.65
+29.9%
$22.50
+298.2%
-72.6%$112.54MN/A-2.8731High Trading Volume
ANIX
ANIXA BIOSCIENCES
3.0898 of 5 stars
$3.43
-0.3%
$9.00
+162.4%
+11.4%$110.81M$210K-9.035Positive News
CTOR
Citius Oncology
1.6958 of 5 stars
$1.48
-3.3%
$3.00
+102.7%
N/A$109.47MN/A0.00N/APositive News
Gap Up
ATOS
Atossa Genetics
3.0234 of 5 stars
$0.85
+0.8%
$6.17
+626.6%
-40.4%$108.75MN/A-4.048News Coverage
Positive News
SAVA
Cassava Sciences
4.1424 of 5 stars
$2.30
+4.1%
$54.50
+2,269.6%
-81.6%$106.76MN/A-1.5330Positive News
CRBP
Corbus Pharmaceuticals
4.792 of 5 stars
$8.56
+0.7%
$50.88
+494.3%
-83.3%$104.02MN/A-2.0340
HLVX
HilleVax
1.9781 of 5 stars
$2.05
-0.5%
$2.00
-2.4%
+15.0%$103.29MN/A-0.9520

Related Companies and Tools


This page (NASDAQ:DYAI) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners